ZETA delivers sub-millimeter targeting accuracy (0.45 mm mean translational error), compared with 2–5 mm reported in many existing TMS navigation systems.

By maintaining on-target coil positioning, navigation preserves cortical dose fidelity—avoiding reductions that can fall to less than half of the intended electric field with misalignment.

As accelerated protocols such as SNT demonstrate remission rates of 57% in randomized trials and up to 90% in open-label studies, precise and consistent targeting becomes essential to fully realize their therapeutic potential.

Real-time AI-powered tracking automates patient registration and motion compensation, reducing operator-dependent variability.

The system is designed for technician-led operation, minimizing reliance on specialist time while maintaining anatomical precision.

With setup in approximately one minute, daily workflows become more predictable and treatment capacity increases across providers.

Under ZETA’s AI-enabled workflow, a single TMS suite can support up to five full treatment courses per week—maximizing clinical capacity within a standard outpatient room.

A technician-led operating model reduces specialist time requirements while supporting scalable, economically efficient outpatient delivery.

With setup times of approximately one minute—compared to more than ten minutes in many existing systems—navigation increases daily treatment throughput per suite.

Deployment in minutes and single-cart portability enable seamless integration into outpatient clinics without dedicated navigation infrastructure.

RealTrack™ AI technology provides automatic, real-time patient registration and tracking, maintaining precision even during patient movement.